Nutrition and Metabolic Insights最新文献

[This corrects the article DOI: 10.1177/11786388241297143.].

Background: Metabolic syndrome (MetS) is defined as the existence of metabolic profile risk factors and impaired glycemic status such as dysglycemia, hyperinsulinemia, insulin resistance (IR), dyslipidemia, and hypertension. Several studies demonstrated that a diet that promotes proper nutritional intake; plays a critical role in the prevention and control of MetS. Our goal for conducting this cross-sectional study was to investigate any potential relationships between the nutrient adequacy ratio (NAR) and cardiometabolic risk variables within obese individuals. individuals.

Methods: In the present cross-sectional study, 338 seemingly healthy participants who were overweight or obese were enrolled. The assessment of dietary consumption was conducted through a validated questionnaire comprising 168 items Then NAR was calculated for all ten vitamins and six minerals. Biochemical variables are measured by the method of enzyme-linked immunosorbent assay (ELISA). Also, LDL-C (low-density lipoprotein-cholesterol), QUICKI (quantitative insulin-sensitivity check index), and HOMA-IR (Homeostatic Model Assessment for Insulin Resistance) were calculated using the suggested formulas.

Results: Subjects in the upper NAR tertiles exhibited a significantly higher percentage of fat-free mass (P = .002), appetite (P = .002), and basal metabolic rate (BMR) (P = .002). In addition, Participants in the upper tertiles of NAR consumed a greater amount of energy and all vitamins and minerals included in NAR and meat, fish and poultry (MFP) (P < .001) as well as cholesterol, monounsaturated fatty acid (MUFA), and polyunsaturated fatty acid (PUFA) (P < .05). Furthermore, no association was shown between NAR and metabolic profile and glycemic status.

Conclusion: According to our findings, a higher nutrient adequacy ratio (NAR) was associated with higher fat-free mass but no significant link between NAR and metabolic profile risk factors was observed.

University students are often exposed to various stressors related to academic demands, which increases their susceptibility to psychological distress. Intake of omega-3 fatty acid (N-3 FA) has been found to be negatively correlated with both depression and eating disorder symptoms in non-Saudi individuals. The objective of this study was to evaluate the following among female undergraduate students in Jeddah, Saudi Arabia: (1) prevalence of psychological distress and binge eating disorder (BED); (2) Association between intake of N-3 FA sources and psychological distress; (3) Association between intake of N-3 FA sources and BED. This is a cross-sectional study including 149 female students enrolled in King Abdulaziz University. Participants completed an online questionnaire consisting of previously validated questions that evaluate psychological distress (Kessler 10), BED (Eating Disorders Diagnostic Scale), and N-3 FA intake. Descriptive statistics and logistic regression analysis were performed to analyze the data. The prevalence of mild, moderate, and severe psychological distress was 21.5%, 28.9%, and 28.20%, respectively. The prevalence of BED was 3.40%. Participants who consumed fish at least once per week for 6 months had significantly lower odds of moderate or severe psychological distress (odds ratio (OR): 0.34, 95% confidence interval (CI): 0.13, 0.86, P-value: .02). We did not detect significant associations between intake of N-3 FA sources and BED. Prevalence of psychological distress was higher what has been previously reported in other studies. However, prevalence of BED in our Saudi sample was lower than what has been previously found in other samples. Intake of N-3 FA from fish sources might be associated with lower odds of psychological distress but not with BED. Future studies are needed in order to further establish the need for developing educational programs to enhance N-3 FA intake for promoting mental wellbeing particularly among female young adults.

Background: Although a palaeolithic diet promotes healthier food choices that aid in weight management and reduce cardiovascular risks, its effectiveness in endurance sports is still debated due to its typically low carbohydrate content.

Objective: This study examined the impact of a 6-week palaeolithic diet (PD-G) versus a mixed diet (MD-G), both paired with Sprint interval training (SIT), on various metabolic and performance-related parameters.

Methods: Body composition, time trial (TT) performance (covered distance during a 60-minute run on a 400-metre track) and changes in metabolic (respiratory exchange ratio [RER], substrate oxidation rates) and performance-related (time at ventilatory threshold [VT] and respiratory compensation point [RCP], maximum oxygen uptake (V̇O_2max) and time to exhaustion [TTE]) parameters during a ramp incremental running test were assessed in 14 male endurance athletes. Additionally, Gastrointestinal Quality of Life index (GLQI) and perceptual responses to the diets [visual analogue scale (VAS)] were measured.

Results: After 6 weeks, both groups improved in TTE and distance covered in the 60-minute TT, without significant group differences. In the PD-G body weight, fat mass and systolic and diastolic blood pressure decreased. At rest, RER and carbohydrate oxidation significantly decreased in the PD-G, with a tendency towards significance during exercise, while changes in fat oxidation rates were not statistically significant at rest and throughout the exercise test; in contrast, the MD-G exhibited smaller changes across these parameters.

Conclusion: In this investigation, a palaeolithic diet in combination with SIT appeared to have positive effects on fat mass, blood pressure and substrate utilization under resting conditions in a group of male endurance athletes. However, based on the current findings for performance metrics, a palaeolithic diet cannot be recommended unreservedly for healthy endurance athletes.

Introduction: Any alteration in nutritional status can compromise the progression of breast cancer, as well as the tolerance and efficacy of chemotherapy. The aims of our study were to assess the nutritional status of breast cancer patients treated with chemotherapy and to identify nutritional factors that may exacerbate chemo-induced digestive toxicity.

Methods: This descriptive cross-sectional study was conducted within the medical oncology department of the National Institute of Salah Azaiez. A Mediterranean Diet Score (MDS) was used to evaluate the level of adherence to the Mediterranean Diet. Nutritional status was assessed using 2 methods; body composition evaluation utilising the TANITA BC 601 impedance metre and High authority of health (HAS) criteria of malnutrition. Digestive effects were assessed with World Health Organization (WHO) grades ranging from 0 to 4. High grades 3 and 4 signified toxic grades.

Results: We enrolled 107 adult women diagnosed with breast cancer undergoing the same chemotherapy protocol. The participants had an average age of 52.56 ± 9.75 years and an average BMI of 29.85 ± 5.72 kg/m² with 78.5% classified as overweight. Malnutrition was observed in 41% of patients, while sarcopenia was present in 12%. Chemotherapy-related adverse effects were predominantly constipation (80%), diarrhea (73%), nausea (70%) and vomiting (63.4%) with one-third experiencing high-grade toxicity. Strong adherence to Mediterranean Diet was observed in 48.6% of cases and higher MDS scores were inversely correlated with the severity of nausea (P = .01) and constipation (P = .02). Malnutrition was significantly associated with all digestive toxicities except with constipation. Sarcopenia was associated only with vomiting (P = .005).

Conclusion: There is a relationship between nutritional status and digestive toxicity, justifying early nutritional treatment to improve the tolerance and efficacy of chemotherapy.

Increasing dietary intake of fish oil is frequently recommended for decreasing the risk for cardiovascular diseases and improving metabolic health. We hypothesised that dietary intake of chromista oil (a marine food product and a rich source of long-chain n-3 polyunsaturated fatty acids) ameliorates metabolic impairments in mice with established excess adiposity. Three-to 4-week-old mice (male) were fed a control (n = 12) or a high-fat diet (HFD, n = 24) for 12 weeks to establish body fat mass. Then, mice on the HFD were assigned to 2 groups (n = 12 each) with 1 continuing being fed the HFD and the other fed the HFD with chromista oil for an additional 12 weeks. Intake of chromista oil did not affect body weight and body adiposity of the mice fed the HFD; mice fed the HFD had significantly more body weight and fat mass than control mice. The flattened daily oscillations of respiratory exchange ratio induced by the HFD were not changed by chromista oil intake. Intake of chromista oil significantly increased plasma concentration of insulin, the calculated value of HOMA-IR, and plasma concentration of adiponectin in the mice fed the HFD. However, blood glucose was unaffected by chromista oil. Transcription of genes encoding circadian rhythm and fatty acid metabolism of the 2 HFD-fed groups were similar. Untargeted metabolomic analysis showed that intake of chromista oil altered the hepatic metabolomic profile with substantial alterations in amino acid metabolism. Findings from this study indicate that dietary intake of chromista oil does not improve glucose homeostasis or alter the diminished metabolic flexibility in mice with excess adiposity induced by the HFD. argeted metabolomic analysis is warranted to investigate the effects of dietary chromista oil, as a source of n-3 poly unsaturated fatty acids, on metabolism in models of obesity.

Background: This study investigates the association between dietary flavonoid intake and the incidence of mild cognitive impairment (MCI) through a matched case-control design.

Methods: Dietary intake was assessed using a food frequency questionnaire, comparing the intake of flavonoids between individuals with MCI and those with normal cognitive function. Logistic regression analysis was employed to evaluate the correlation between dietary flavonoid intake and the risk of MCI. Additionally, blood concentrations of S100β, a marker of the blood-brain barrier (BBB) integrity, were measured using electrochemiluminescence immunoassay, and Pearson correlation analysis was conducted to explore the relationship between dietary flavonoid intake and blood S100β levels.

Results: Compared to participants with normal cognition, those with MCI had significantly lower dietary intakes of total flavonoids, isoflavones, daidzein, glycitein, genistein, kaempferol, myricetin, flavonols, and anthocyanidins, while the intake of peonidin was significantly higher. Univariate logistic regression analysis indicated that high dietary intake of total flavonoids, isoflavones, daidzein, glycitein, genistein, kaempferol, myricetin, and flavonols was negatively correlated with MCI, whereas peonidin intake was positively correlated with MCI. Multivariate logistic regression analysis confirmed these findings. Pearson correlation analysis revealed a significant negative correlation between dietary intake of kaempferol and myricetin and blood S100β levels.

Conclusion: Increasing the dietary intake of total flavonoids, isoflavones, daidzein, glycitein, genistein, and flavonols appears to be a protective factor against MCI, while higher intake of peonidin is associated with an increased risk of MCI. The protective or adverse effects of these flavonoids may not be related to the permeability of the BBB. Myricetin and kaempferol intake may protect cognitive function by maintaining BBB integrity.

Background: The autonomic nervous system (ANS) is affected by several factors, including major nutrients. However, their effects on the ANS remains unclear. Most studies had several limitations. They focused on humans, therefore they had difficulties excluding factors other than the nutrients. Their observation periods were too short (<4 hours) to align with typical absorption times of carbohydrates versus fats. They assessed the effects compared with the pre-prandial state rather than comparisons between different nutrient types.

Objective: We aimed to investigate the effects of carbohydrates and fats on the ANS.

Method: We employed a rat model to exclude the effects of external stimuli, used sufficient observation period, and compared the ANS parameters among animals fed 3 different diets. The rats were divided into carbohydrate-rich-diet (carb group) and fat-rich-diet (fat group) groups. We investigated the effects of carbohydrates and fats on the ANS by measuring heart rate variability parameters in rats. Electrodes and electrocardiography (ECG) transmitters were implanted in 14 Wistar rats maintained on a standard diet for 2 days followed by the experimental diets for 2 days. ECG readings were continuously recorded for 4 days. The R waves, function of the R-R interval, and time were calculated. A fast Fourier transform was used to obtain the power spectrum of the fluctuation (low frequency [LF: 0.2-0.75 Hz]; high frequency [HF: 0.75-3.0 Hz]; LF/HF ratio).

Result: Compared with the standard-diet group, the carb group showed significantly increased HF activity, while the fat group showed a significantly increased LF/HF ratio.

Conclusion: The results reveal a link between macronutrients and ANS activity.

Background: Individuals who have hyperuricemia are at increased risk of cardiovascular diseases due to factors such as endothelial dysfunction, insulin resistance, and increased production of oxygen-free radicals. However, data on the prevalence and predictors of hyperuricemia among adults with cardiac diseases in Ethiopia are limited.

Methods: A cross-sectional study was conducted on 269 participants at the Ambo University referral hospital from June to September, 2022. Participant demographics and relevant data were obtained through convenient sampling. Hyperuricemia was defined according to the manufacturer's cutoff criteria. Data entry and analysis were conducted using SPSS 25. The association between the outcome and explanatory variables was assessed using a binary logistic regression model.

Results: Of the study participants, 56.9% were male. The mean age of participants was 51.1 years (±15.8). The prevalence of hyperuricemia was 43.1% (95% CI: 37.1-49.1). Males presented a significantly higher prevalence of hyperuricemia compared to females (23.4% vs 19.7%, P = .026). Males had 2.9 times higher odds of hyperuricemia compared to females. Significant associations with the prevalence of hyperuricemia were found for individuals with a BMI ⩾30 kg/m², age ⩾54 years, and male gender, with adjusted odds ratios (95% CI) of 2.3 (1.7-5.2), 2.9 (2.2-5.9), and 3.56 (2.1-12.8), respectively. Additionally, smoking, dyslipidemia, and waist circumference were also significantly associated with the prevalence of hyperuricemia.

Conclusions: Nearly half of the cardiac patients in the study were diagnosed with hyperuricemia. These findings underscores the importance of early identification and treatment of hyperuricemia, alongside lifestyle and behavioral modifications, to maintain the quality of life in this specific population.

Sinusitis, one of the most prevalent and undertreated disorders, is a term used to describe inflammation of the paranasal sinuses caused by either infectious or non-infectious sources. Bacterial, viral, or fungal infections can all cause sinusitis. Sinusitis is classified into 3 types: acute, subacute, and chronic. Acute sinusitis lasts for less than 1 month, subacute sinusitis lasts from 1 to 3 months, and chronic sinusitis persists for over 3 months. This condition affects a significant portion of the population, imposing a substantial burden on the healthcare system. Antibiotics are the gold standard of bacterial sinusitis treatment. However, due to the rise of antimicrobial resistance, especially in immune-compromised patients, it is necessary to investigate potential adjunctive therapies. Based on the literature, vitamins (eg, vitamin D) have antioxidant, anti-inflammatory, and immune-modulatory properties and may effectively treat sinusitis and reduce mucous membrane inflammation. Besides vitamins, many other supplements like quercetin, sinupret, and echinacea have immunomodulatory effects and have shown promising results in sinusitis treatment. In this review, we look at the therapeutic role, safety, and efficacy of vitamins and nutritional supplements in sinusitis treatment.